Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Science, 2020-06, Vol.368 (6497), p.1331-1335 [Peer Reviewed Journal]

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. ;2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works ;Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). 2020 The Authors ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abb4489 ;PMID: 32321856

Digital Resources/Online E-Resources